Open AccessClinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C
Author(s) -
Hideyuki Suzuki
Publication year - 2010
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v2.i11.401
Subject(s) - ribavirin , medicine , titer , hepatitis c virus , gastroenterology , viral load , pegylated interferon , immunology , hepatitis c , interferon , virus , virology
To predict which chronic hepatitis C patients are likely to be late-responders, we herein investigated the clinical characteristics of null-responders at 36 wk with hepatitis C virus (HCV) genotype Ib and a high viral load during the course of pegylated interferon (Peg-IFN)/ribavirin therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom